INDEPENDENT DIRECTOR AGREEMENT
THIS INDEPENDENT DIRECTOR AGREEMENT (“ Agreement ”) is made effective as of May 8,
2010 by and between HUIFENG BIO-PHARMACEUTICAL TECHNOLOGY, INC., a Nevada Corporation
(“ Company ”), and LUI CHI KEUNG (“ Director ”).
WHEREAS, it is essential to the Company to attract and retain as directors the most capable persons
available to serve on the board of directors of the Company (the “ Board ”); and
WHEREAS, the Company believes that Director possesses the necessary qualifications and abilities to
serve as a director of the Company and to perform the functions and meet the Company’s needs related to its
NOW, THEREFORE, the parties agree as follows:
1. Service as Director and Chairperson of Audit Committee . Director will serve as a director of the
Company for one year since the date hereof in accordance with the bylaws of the Company and perform all
duties as a director of the Company, including without limitation (1) attending meetings of the Board, (2) serving
as the Audit Committee Chairperson along with other committees of the Board (each a “ Committee ”) and
attending meetings of each Committee of which Director is a member and (3) act in a good manner not opposed
to the best interests of the Company.
2. Compensation and Expenses .
(a) Director Compensation . The Company will pay to Director an annual stock grant (the “
Compensation ”) of 30,000 shares of the Company’s restricted common stock (“ Stock ”). Such Stock shall be
delivered on December 31 of each year of service, as adjusted below. The Board reserves the right to increase
the Compensation from time to time, but may not reduce the Compensation below the amounts stated above. If
Director’s service on the Board or any Committee begins or ends prior to completion of one year, as measured
from the effective date, and each succeeding anniversary of the effective date, the Compensation for that year will
be prorated on a per diem basis as appropriate to reflect the po